Merck says study shows COVID-19 pill works vs variants
Deena Beasley, Reuters
Posted at Sep 30 12:14 PM
Laboratory studies show that Merck & Co's experimental oral COVID-19 antiviral drug, molnupiravir, is likely to be effective against known variants of the coronavirus, including the dominant, highly transmissible Delta, the company said on Wednesday. Read more »